SARS-CoV-2, COVID-19 and the eye: An update on published data

A. Rousseau; J. R. Fenolland; M. Labetoulle

doi:10.1016/j.jfo.2020.05.003

SARS-CoV-2, COVID-19 and the eye: An update on published data

Titre traduit de la contribution: SARS-CoV-2, COVID-19 et œil: le point sur les données publiées

A. Rousseau
, J. R. Fenolland
, M. Labetoulle

Université Paris-Saclay
Institut de Radioprotection et de Sûreté Nucléaire
Hôpital d'Instructions des Armées Bégin

Résultats de recherche: Contribution à un journal › Article de révision › Revue par des pairs

Résumé

The COVID-19 pandemic has dramatically changed our daily lives as ophthalmologists. This general review firstly provides a better understanding of the virus responsible for the pandemic: the SARS-CoV-2, and the clinical manifestations of the COVID-19 disease. The second part is detailing the pathophysiology, clinical signs and challenges of ocular involvement, which seems rare and not functionally severe, but which may be a potential source of contamination. Finally, we discuss the preventive measures that need to be implemented in our daily practice to avoid any viral dissemination.

Titre traduit de la contribution	SARS-CoV-2, COVID-19 et œil: le point sur les données publiées
langue originale	Anglais
Pages (de - à)	642-652
Nombre de pages	11
journal	Journal Francais d'Ophtalmologie
Volume	43
Numéro de publication	7
Les DOIs	https://doi.org/10.1016/j.jfo.2020.05.003
état	Publié - 1 sept. 2020
Modification externe	Oui

Accès au document

10.1016/j.jfo.2020.05.003

Contient cette citation

@article{066bfebfe71743d286dce5005345607c,

title = "SARS-CoV-2, COVID-19 and the eye: An update on published data",

abstract = "The COVID-19 pandemic has dramatically changed our daily lives as ophthalmologists. This general review firstly provides a better understanding of the virus responsible for the pandemic: the SARS-CoV-2, and the clinical manifestations of the COVID-19 disease. The second part is detailing the pathophysiology, clinical signs and challenges of ocular involvement, which seems rare and not functionally severe, but which may be a potential source of contamination. Finally, we discuss the preventive measures that need to be implemented in our daily practice to avoid any viral dissemination.",

keywords = "COVID-19, COVID-19, Conjonctivite, Conjunctivitis, Larmes, Ocular surface, SARS-CoV-2, SARS-CoV-2, Surface oculaire, Tears, Transmission, Transmission",

author = "A. Rousseau and Fenolland, \{J. R.\} and M. Labetoulle",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Masson SAS",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.jfo.2020.05.003",

language = "English",

volume = "43",

pages = "642--652",

journal = "Journal Francais d'Ophtalmologie",

issn = "0181-5512",

number = "7",

}

TY - JOUR

T1 - SARS-CoV-2, COVID-19 and the eye

T2 - An update on published data

AU - Rousseau, A.

AU - Fenolland, J. R.

AU - Labetoulle, M.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - The COVID-19 pandemic has dramatically changed our daily lives as ophthalmologists. This general review firstly provides a better understanding of the virus responsible for the pandemic: the SARS-CoV-2, and the clinical manifestations of the COVID-19 disease. The second part is detailing the pathophysiology, clinical signs and challenges of ocular involvement, which seems rare and not functionally severe, but which may be a potential source of contamination. Finally, we discuss the preventive measures that need to be implemented in our daily practice to avoid any viral dissemination.

AB - The COVID-19 pandemic has dramatically changed our daily lives as ophthalmologists. This general review firstly provides a better understanding of the virus responsible for the pandemic: the SARS-CoV-2, and the clinical manifestations of the COVID-19 disease. The second part is detailing the pathophysiology, clinical signs and challenges of ocular involvement, which seems rare and not functionally severe, but which may be a potential source of contamination. Finally, we discuss the preventive measures that need to be implemented in our daily practice to avoid any viral dissemination.

KW - COVID-19

KW - Conjonctivite

KW - Conjunctivitis

KW - Larmes

KW - Ocular surface

KW - SARS-CoV-2

KW - Surface oculaire

KW - Tears

KW - Transmission

U2 - 10.1016/j.jfo.2020.05.003

DO - 10.1016/j.jfo.2020.05.003

M3 - Review article

C2 - 32631687

AN - SCOPUS:85087421344

SN - 0181-5512

VL - 43

SP - 642

EP - 652

JO - Journal Francais d'Ophtalmologie

JF - Journal Francais d'Ophtalmologie

IS - 7

ER -

SARS-CoV-2, COVID-19 and the eye: An update on published data

Résumé

Accès au document

Empreinte digitale

Contient cette citation